Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Reticulocyte Ratio and Neutrophil / Lymphocyte Ratio in the Diagnosis of Ventilator-associated Pneumonia

NCT04620941 is registered in ClinicalTrials.gov with Muğla Sıtkı Koçman University as lead sponsor.

NCT NCT04620941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04620941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Reticulocyte Ratio and Neutrophil / Lymphocyte Ratio in the Diagnosis of Ventilator-associated Pneumonia
Lead sponsor
Muğla Sıtkı Koçman University
Phase
Observational
Overall status
Completed
Start date
February 21, 2022
Completion date
December 21, 2023
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ventilator-associated pneumonia (vap)